Fortress Biotech Inc (FBIO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.51 (+0.00%), Market cap $0.08B, 52-week low–high $1.70 ~ $4.38.
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a minocycline topical foam for the treatment of lesions of rosacea; Exelderm, an antifungal cream for topical use; Targadox, an oral doxycycline drug for the th
Financial statements, price targets, institutional (13F) holdings and related news for Fortress Biotech Inc are updated in real time on BlackAll Trade.
Fortress Biotech Inc trades at $2.51 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Fortress Biotech Inc has a market cap of about $0.08B.
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extende